DRRX Durect Corporation

USD 0.70 -0.03 ( -4.46%)
Icon

Durect Corporation (DRRX) Financial Statements

COMMON STOCK | Drug Manufacturers - Specialty & Generic | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.70

-0.03 (-4.46%)

USD 0.03B

0.13M

USD 5.00(+615.61%)

USD 6.00 (+758.74%)

Icon

DRRX

Durect Corporation (USD)
COMMON STOCK | NSD
USD 0.70
-0.03 ( -4.46%)

Durect Corporation (DRRX) Annual Income Statement (USD)

DRRX Quarterly Financials (USD)

Frequently Asked Questions About Durect Corporation (DRRX) Stock

Durect Corporation's (DRRX) last reported annual revenue was USD 8.55 Million.

Durect Corporation's (DRRX) annual revenue growth rate based on the revenue reported in the past 5 years is : -14.37%

Durect Corporation's(DRRX) is not profitable as of its last reported annual financials.

The net profit margin for Durect Corporation's(DRRX) from its laster reported year is -323.16%

The return on equity (ROE) for Durect Corporation's(DRRX) from its last reported annual financials is : -218.51%

The return on assets (ROA) for Durect Corporation's(DRRX) from its last reported annual financials is : -30.68%

The return on invested capital (ROIC) for Durect Corporation's(DRRX) from its last reported annual financials is : -78.86%

The Debt to Equity ratio for Durect Corporation's(DRRX) from its last reported annual financials is : 0.00%

The dividend yield for Durect Corporation's(DRRX) from its laster reported year is 0.00%

Durect Corporation's(DRRX) has negative cash flow as of its last reported annual financials.

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...